1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Hashimoto, Y. Toma, K. Nishikido, J. Yamamoto, K. Haneda, K. Inazu, T. Valentine, K. Opella, S.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C6 H12 O6 180.156 alpha-D-mannopyranose D-saccharide, alpha linking C8 H15 N O6 221.208 2-acetamido-2-deoxy-beta-D-glucopyranose D-saccharide, beta linking H2 N 16.023 AMINO GROUP non-polymer C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 38 8377 8384 10.1021/bi983018j 10387083 Effects of glycosylation on the structure and dynamics of eel calcitonin in micelles and lipid bilayers determined by nuclear magnetic resonance spectroscopy. 1999 MAN B 3 HAS WRONG CHIRALITY AT ATOM C1 NAG B 1 HAS WRONG CHIRALITY AT ATOM C1 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 SYNTHETICALLY GLYCOSYLATED AT ASN3 3419.906 PROTEIN (CALCITONIN) 1 syn polymer 1397.245 alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose 1 man branched no yes CSNLSTCVLGKLSQELHKLQTYPRTDVGAGTP(NH2) CSNLSTCVLGKLSQELHKLQTYPRTDVGAGTPX A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n atom_site chem_comp database_PDB_caveat entity pdbx_branch_scheme pdbx_chem_comp_identifier pdbx_entity_branch pdbx_entity_branch_descriptor pdbx_entity_branch_link pdbx_entity_branch_list pdbx_entity_nonpoly pdbx_nmr_software pdbx_nonpoly_scheme pdbx_struct_assembly_gen pdbx_validate_chiral struct_asym struct_conn struct_site struct_site_gen repository Initial release Carbohydrate remediation repository Remediation Version format compliance Non-polymer description Version format compliance Advisory Atomic model Data collection Derived calculations Structure summary 1 0 1998-11-11 1 1 2008-04-27 1 2 2011-07-13 2 0 2020-07-29 _atom_site.Cartn_x _atom_site.Cartn_y _atom_site.Cartn_z _atom_site.auth_asym_id _atom_site.auth_atom_id _atom_site.auth_comp_id _atom_site.auth_seq_id _atom_site.label_asym_id _atom_site.label_atom_id _atom_site.label_comp_id _atom_site.label_entity_id _atom_site.type_symbol _chem_comp.name _chem_comp.type _pdbx_nmr_software.name _pdbx_struct_assembly_gen.asym_id_list _struct_conn.pdbx_dist_value _struct_conn.pdbx_leaving_atom_flag _struct_conn.pdbx_role _struct_conn.pdbx_value_order _struct_conn.ptnr1_auth_asym_id _struct_conn.ptnr1_auth_comp_id _struct_conn.ptnr1_auth_seq_id _struct_conn.ptnr1_label_asym_id _struct_conn.ptnr1_label_atom_id _struct_conn.ptnr1_label_comp_id _struct_conn.ptnr1_label_seq_id _struct_conn.ptnr2_auth_asym_id _struct_conn.ptnr2_auth_comp_id _struct_conn.ptnr2_auth_seq_id _struct_conn.ptnr2_label_asym_id _struct_conn.ptnr2_label_atom_id _struct_conn.ptnr2_label_comp_id _struct_conn.ptnr2_label_seq_id NAG 33 n B NAG 1 NAG 34 n B NAG 2 MAN 35 n B MAN 3 MAN 37 n B MAN 4 MAN 40 n B MAN 5 MAN 36 n B MAN 6 MAN 39 n B MAN 7 MAN 38 n B MAN 8 DManpa a-D-mannopyranose a-D-Manp Man DGlcpNAcb N-acetyl-b-D-glucopyranosamine b-D-GlcpNAc GlcNAc BNL Y RCSB 1998-10-27 REL REL oligosaccharide DManpa1-2DManpa1-3[DManpa1-3[DManpa1-6]DManpa1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1- 2 GMML 1.0 Glycam Condensed Sequence WURCS=2.0/2,8,7/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1a_1-5]/1-1-2-2-2-2-2-2/a4-b1_b4-c1_c3-d1_c6-f1_d2-e1_f3-g1_f6-h1 2 PDB2Glycan 1.1.0 WURCS []{[(4+1)][b-D-GlcpNAc]{[(4+1)][b-D-GlcpNAc]{[(4+1)][b-D-Manp]{[(3+1)][a-D-Manp]{[(2+1)][a-D-Manp]{}}[(6+1)][a-D-Manp]{[(3+1)][a-D-Manp]{}[(6+1)][a-D-Manp]{}}}}}} 2 PDB-CARE LINUCS C1 O4 NAG NAG 2 1 2 O1 HO4 sing C1 O4 MAN NAG 3 2 2 O1 HO4 sing C1 O3 MAN MAN 4 3 2 O1 HO3 sing C1 O2 MAN MAN 5 4 2 O1 HO2 sing C1 O6 MAN MAN 6 3 2 O1 HO6 sing C1 O3 MAN MAN 7 6 2 O1 HO3 sing C1 O6 MAN MAN 8 6 2 O1 HO6 sing n n n n n n n n THIS SEQUENCE OCCURS NATURALLY IN ANGUILLA JAPONICA (JAPANESE EEL) sample THE STRUCTURE WAS DETERMINED USING A SERIES OF 2D NMR SPECTROSCOPY ON UNLABLED SAMPLE. SODIUM DODECYL SULFATE (SDS) WAS ADDED TO THE NMR SAMPLE AT A SDS/ PEPTIDE RATIO OF 100/1. VIOLATION 20 10 NOESY DQF-COSY TOCSY 4.5 308 K distance geometry HAVEL refinement DGII structure solution Felix 750 Bruker DMX750 CYS 1 n 1 CYS 1 A SER 2 n 2 SER 2 A ASN 3 n 3 ASN 3 A LEU 4 n 4 LEU 4 A SER 5 n 5 SER 5 A THR 6 n 6 THR 6 A CYS 7 n 7 CYS 7 A VAL 8 n 8 VAL 8 A LEU 9 n 9 LEU 9 A GLY 10 n 10 GLY 10 A LYS 11 n 11 LYS 11 A LEU 12 n 12 LEU 12 A SER 13 n 13 SER 13 A GLN 14 n 14 GLN 14 A GLU 15 n 15 GLU 15 A LEU 16 n 16 LEU 16 A HIS 17 n 17 HIS 17 A LYS 18 n 18 LYS 18 A LEU 19 n 19 LEU 19 A GLN 20 n 20 GLN 20 A THR 21 n 21 THR 21 A TYR 22 n 22 TYR 22 A PRO 23 n 23 PRO 23 A ARG 24 n 24 ARG 24 A THR 25 n 25 THR 25 A ASP 26 n 26 ASP 26 A VAL 27 n 27 VAL 27 A GLY 28 n 28 GLY 28 A ALA 29 n 29 ALA 29 A GLY 30 n 30 GLY 30 A THR 31 n 31 THR 31 A PRO 32 n 32 PRO 32 A NH2 41 n 33 NH2 41 A author_defined_assembly 1 monomeric A ASN 3 GLYCOSYLATION SITE A ASN 3 ASN 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 2 A NH1 ARG 24 A NH1 ARG 24 1 Y 1 B C1 MAN 3 WRONG HAND 4 B C1 NAG 1 WRONG HAND 10 B C1 NAG 1 WRONG HAND 8 A A SER ASN 2 3 148.58 1 A TYR 22 0.076 SIDE CHAIN 10 A TYR 22 0.065 SIDE CHAIN 1 A ASN 3 -55.17 -70.95 1 A SER 5 -158.68 -72.99 1 A ARG 24 -160.55 103.37 1 A ASP 26 64.30 67.94 2 A SER 2 -88.80 45.89 2 A ASN 3 -179.19 -46.08 2 A SER 5 -162.49 -63.33 2 A GLN 20 53.37 -84.57 2 A PRO 23 -64.95 -174.79 2 A THR 25 -161.67 -51.40 2 A ALA 29 70.79 -66.73 3 A SER 5 -114.90 -82.81 3 A THR 21 -88.28 44.27 3 A TYR 22 65.45 127.32 3 A ASP 26 59.70 78.31 3 A ALA 29 -154.23 79.52 4 A SER 2 76.47 -49.87 4 A SER 5 -151.94 -63.05 4 A TYR 22 55.68 70.58 4 A ASP 26 53.38 -107.67 4 A THR 31 58.71 73.71 5 A SER 2 -140.47 -48.81 5 A SER 5 -158.43 -64.54 5 A TYR 22 61.64 72.52 5 A ASP 26 -156.88 75.29 5 A ALA 29 67.54 179.93 6 A SER 2 -154.05 40.26 6 A ASN 3 168.41 -31.77 6 A LEU 4 70.57 70.98 6 A SER 5 -142.37 -72.27 6 A TYR 22 48.34 83.42 7 A SER 2 92.49 -38.51 7 A SER 5 -161.04 -55.29 7 A LEU 19 -68.93 -79.46 7 A GLN 20 63.60 -80.25 7 A ASP 26 69.57 -77.65 7 A VAL 27 -130.40 -34.46 7 A ALA 29 51.89 80.10 8 A SER 2 -50.21 -85.25 8 A ASN 3 179.58 148.12 8 A SER 5 168.14 -61.19 8 A TYR 22 47.82 90.41 8 A ARG 24 60.96 82.17 8 A THR 25 -88.81 49.42 8 A ASP 26 -172.56 70.45 9 A ASN 3 50.31 -167.22 9 A LEU 4 -148.67 54.49 9 A SER 5 -139.28 -65.50 9 A GLN 20 26.95 60.96 9 A VAL 27 -143.20 57.01 10 A SER 2 56.61 -103.90 10 A SER 5 -137.36 -62.19 10 A GLN 20 54.44 -87.79 10 A TYR 22 63.08 88.79 10 A ALA 29 61.10 -170.77 PROTEIN (CALCITONIN) GLYCOSYLATED EEL CALCITONIN 1 N N 2 N N A SER 5 A SER 5 HELX_P A LEU 19 A LEU 19 5 H1 15 disulf 2.036 A CYS 1 A SG CYS 1 1_555 A CYS 7 A SG CYS 7 1_555 covale 1.452 one N-Glycosylation A ASN 3 A ND2 ASN 3 1_555 B NAG 1 B C1 NAG 1_555 covale 1.336 both A PRO 32 A C PRO 32 1_555 A NH2 41 A N NH2 33 1_555 covale 1.395 both sing B NAG 1 B O4 NAG 1_555 B NAG 2 B C1 NAG 1_555 covale 1.395 both sing B NAG 2 B O4 NAG 1_555 B MAN 3 B C1 MAN 1_555 covale 1.417 both sing B MAN 3 B O3 MAN 1_555 B MAN 4 B C1 MAN 1_555 covale 1.400 both sing B MAN 3 B O6 MAN 1_555 B MAN 6 B C1 MAN 1_555 covale 1.416 both sing B MAN 4 B O2 MAN 1_555 B MAN 5 B C1 MAN 1_555 covale 1.420 both sing B MAN 6 B O3 MAN 1_555 B MAN 7 B C1 MAN 1_555 covale 1.400 both sing B MAN 6 B O6 MAN 1_555 B MAN 8 B C1 MAN 1_555 HORMONE/GROWTH FACTOR HORMONE, CALCIUM-REGULATOR, OSTEOPOROSIS, HORMONE-GROWTH FACTOR COMPLEX CALC_ANGJA UNP 1 P01262 1 32 1BZB 1 32 P01262 A 1 1 32 1 P 1